These innovative therapies , Semaglutide , represent a remarkable advancement in treating type 2 diabetes and conceivably other ailments . These drugs are classified as GLP-1 pathway activators , signifying they function to emulate the endogenous GLP-1 peptide, enhancing metabolic secretion and lowering hunger . Despite Tirzepatide each operates re